Cancer
Researchers at the Fourth Affiliated Hospital of Harbin Medical University have made a significant discovery in the field of nanotechnology, designing a novel polysaccharide-based fluorescent nanocarrier system, HPMC-AuNPs@1, for the delivery of plant extract compound 1. This nanocarrier system has shown great promise in detecting carcinoembryonic antigen (CEA) and
Cancer research
Research conducted in Lyon, France, suggests that eating a diverse diet, characterized by a wide variety of species, may contribute to reduced risk of gastrointestinal cancer. A study published in the American Journal of Clinical Nutrition found that individuals consuming more diverse diets had lower levels of certain amino acids
Cancer research
A recent study published in Frontiers in Immunology has shed new light on the role of myeloperoxidase (MPO) in gastric cancer. Researchers from Sichuan University, led by Junteng Zhou, analyzed data from 16,943 healthy individuals and 375 gastric adenocarcinoma (GA) patients from The Cancer Genome Atlas (TCGA). Their findings
Cancer research
Researchers from the Zhejiang Cancer Hospital and Alibaba's DAMO Academy have developed an AI model, DAMO GRAPE, that can identify early signs of stomach cancer in routine CT scans. The model was tested on over 70,000 patients, yielding promising results. The study, published in the journal Nature
Cancer
A recent study conducted by researchers at Second Affiliated Hospital of Nanjing University of Chinese Medicine in Nanjing, People's Republic of China, has made significant findings in the field of gastric cancer treatment. The research discovered that elevated levels of lactate dehydrogenase (LDH) and certain inflammatory markers can
Cancer
The HER2-positive gastric cancer pipeline is a rapidly evolving space with over 20 companies and 20 pipeline drugs in various stages of development. DelveInsight's report "HER2 Positive Gastric Cancer - Pipeline Insight, 2025" provides a comprehensive analysis of the pipeline therapies, highlighting the promising emerging drugs,
Cancer
Fresh data on gene editing in gastric cancer have been presented by researchers from Chongqing University, shedding light on the enhancer landscape marked by histone H3K27ac modifications in diffuse-type gastric cancer tissues. The study aimed to elucidate the epigenetic remodeling mechanisms by which active enhancers regulate cachexia-related genes. The research
Cancer
Researchers at the University of Miyazaki have made significant discoveries in the treatment of gastric cancer, a type of cancer that is frequently associated with peritoneal metastasis and has a poor prognosis. According to recent research, photodynamic therapy (PDT) using a non-cytotoxic approach with talaporfin sodium (TS) may enhance the
Cancer research
A recent study conducted at the Shiraz University of Medical Sciences in Shiraz, Iran, has shed light on the role of microRNAs (miRNAs) in gastric cancer. The research, which involved 30 gastric cancer patients, aimed to investigate the expression levels of miR-503-5p in the serum of patients before and after
Cancer
New research highlights the importance of managing blood glucose levels in non-diabetic gastric cancer patients after surgery. A study conducted by researchers from the First Affiliated Hospital of Xi'an Jiaotong University found that postoperative hyperglycemia is common in gastric cancer patients, and that it can negatively impact overall
Cancer research
GlycoNex, Inc., a clinical-stage biotechnology company, has announced promising preclinical results for its first-in-class antibody-drug conjugate (ADC), GNX1021, in treating gastric cancer. The company's innovative approach may offer a novel treatment option for patients who are ineligible for existing therapies. With a strong safety profile comparable to that
Cancer
Researchers at Lanzhou University have made significant progress in identifying potential biomarkers for early gastric cancer diagnosis. Through a machine learning-based approach, the team identified several genes associated with immune cell infiltration in the tumor microenvironment. The new biomarkers, including TAGLN2, HSP90AB1, SH3BGRL3, and CFL1, demonstrated strong diagnostic performance and
